Auf dieser Seite
ALGS Aligos Therapeutics, Inc. - Common stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$5,54
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,9852-Wochen-Tief
$13,6952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$35M
P/E (TTM)
-4.8
EPS (TTM)
$-1.16
Umsatz (TTM)
$4M
Ihre Abzeichen
52W-Spanne
$4–$14
Analystenbewertung
BUY
Kursziel
$52
P/E
-4.8
ROE
-113.6%
Nettogewinnmarge
-2031.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ALGS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.54
Marktkapitalisierung (MRQ)
$35M
P/E (TTM)
-4.8
EPS (TTM)
$-1.16
Umsatz (TTM)
$4M
ROE (TTM)
-113.6%
52W-Spanne
$4–$14
ALGS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 19. August 2024 | 1-for-25 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2M2020-12-31 → 2025-12-31
EPS$-2.452022-12-31 → 2025-12-31
Freier Cashflow·2020-12-31 → 2024-12-31
Nettogewinnmarge-2031.1%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ALGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -4.85-Jahres-Durchschnitt ≈-4.2 | ≈-4.2 | · | · | |
| P/S (TTM) | 9.25-Jahres-Durchschnitt ≈90.1 | ≈90.1 | · | · | |
| K/B (MRQ) | 1.15-Jahres-Durchschnitt ≈17.5 | ≈17.5 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -0.45-Jahres-Durchschnitt ≈-28.2 | ≈-28.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.65-Jahres-Durchschnitt ≈23.3 | ≈23.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ALGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -2112.1%5-Jahres-Durchschnitt ≈-2639.1% | ≈-2639.1% | -639.7% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -4024.9%5-Jahres-Durchschnitt ≈-2639.1% | ≈-2639.1% | -639.7% | Schwach | |
| Vorgewinnmarge (TTM) | -1945.1%5-Jahres-Durchschnitt ≈-2040.1% | ≈-2040.1% | · | · | |
| Nettogewinnmarge (TTM) | -2031.1%5-Jahres-Durchschnitt ≈-2052.2% | ≈-2052.2% | -235.8% | Schwach | |
| ROA (TTM) | -75.6%5-Jahres-Durchschnitt ≈-61.8% | ≈-61.8% | -16.9% | Unterdurchschnittlich | |
| ROE (TTM) | -113.6%5-Jahres-Durchschnitt ≈-308.4% | ≈-308.4% | -14.0% | Unterdurchschnittlich | |
| ROIC | -166.5%5-Jahres-Durchschnitt ≈-23.6% | ≈-23.6% | -60.4% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ALGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.25-Jahres-Durchschnitt ≈4.4 | ≈4.4 | 1.9 | Starke Liquidität | |
| Quick Ratio (MRQ) | 2.15-Jahres-Durchschnitt ≈4.1 | ≈4.1 | 0.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ALGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -39.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ALGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$26.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
15.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $-0.14 | $-1.09 | 87.2% |
| 31. März 2026 | $-2.21 | $-2.27 | 2.5% | |
| 31. Dezember 2025 | $-1.91 | $-1.89 | -1.1% | |
| 30. September 2025 | $-3.04 | $-1.94 | -56.9% | |
| 30. Juni 2025 | $-1.53 | $-2.41 | 36.5% | |
| 31. März 2025 | $-2.11 | $-2.85 | 26.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $4M | $6M | $0 | $0 | $0 | |
| R&D Expense | $69M | $70M | $73M | $85M | $104M | $80M | |
| SG&A Expense | $21M | $23M | $31M | $26M | $29M | $18M | |
| Operating Expenses | $90M | $93M | $104M | $111M | $133M | $98M | |
| Operating Income | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M | |
| Pretax Income | $-24M | $-131M | $-87M | $-96M | $-128M | $-108M | |
| Income Tax | $314.0K | $331.0K | $795.0K | $106.0K | $143.0K | $161.0K | |
| Net Income | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| EPS (Basic) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| EPS (Diluted) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| Shares (Basic) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| Shares (Diluted) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| EBITDA | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $37M | $136M | $81M | $187M | $220M | |
| Short-term Investments | $60M | $20M | · | $44M | $4M | $23M | |
| Other Current Assets | $5M | $5M | $5M | $8M | $14M | $6M | |
| Current Assets | $83M | $62M | $141M | $134M | $204M | $250M | |
| PP&E (Net) | $2M | $2M | $3M | $5M | $6M | $8M | |
| PP&E (Gross) | $15M | $14M | $14M | $14M | $13M | $12M | |
| Accum. Depreciation | $13M | $12M | $11M | $10M | $7M | $4M | |
| Other Non-current Assets | $715.0K | $627.0K | $625.0K | $634.0K | $866.0K | $377.0K | |
| Total Assets | $89M | $70M | $152M | $147M | $235M | $265M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $3M | $3M | |
| Accrued Liabilities | $14M | $16M | $17M | $16M | $25M | $17M | |
| Current Liabilities | $21M | $22M | $24M | $33M | $39M | $30M | |
| Capital Leases | $2M | $5M | $8M | $9M | $11M | $10M | |
| Other Non-current Liabilities | · | · | · | · | $133.0K | $379.0K | |
| Total Liabilities | $35M | $99M | $59M | $43M | $51M | $45M | |
| Common Stock | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-642M | $-618M | $-487M | $-399M | $-303M | $-175M | |
| AOCI | $468.0K | $451.0K | $545.0K | $401.0K | $452.0K | $-188.0K | |
| Stockholders' Equity | $54M | $-29M | $92M | $104M | $185M | $220M | |
| Liabilities + Equity | $89M | $70M | $152M | $147M | $235M | $265M | |
| Shares Outstanding | 6,178,230 | 3,864,436 | 3,003,855 | 42,922,980 | 42,690,229 | 38,120,606 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $8M | $13M | $15M | $13M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-83M | $-81M | $-79M | $-79M | $-116M | $-74M | |
| CapEx | · | $130.0K | $19.0K | $943.0K | $892.0K | $2M | |
| Investing Cash Flow | $-38M | $-18M | $45M | $-26M | $3M | $33M | |
| Stock Issued | · | · | $23.0K | · | · | · | |
| Financing Cash Flow | $102M | $355.0K | $88M | $164.0K | $79M | $192M | |
| Taxes Paid | $315.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-81M | $-79M | $-80M | $-117M | $-76M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| Net Margin | -1106.7% | -3633.7% | -1416.2% | · | · | · | |
| Pretax Margin | -1092.4% | -3624.5% | -1403.4% | · | · | · | |
| EBITDA Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| ROA | -30.5% | -118.4% | -58.8% | -50.3% | -51.3% | -52.7% | |
| ROE | -31.1% | -1242.4% | -119.4% | -85.0% | -63.9% | -260.4% | |
| ROIC | -166.5% | 308.5% | -96.6% | -94.0% | -69.5% | -44.5% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 | 8.3 | |
| Quick Ratio | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 | 8.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.67 | $-7.50 | $1.23 | $2.42 | $4.33 | $6.01 | |
| Revenue / Share | $0.22 | $0.58 | $0.10 | · | · | · | |
| Cash Flow / Share | $-8.35 | $-12.89 | $-1.23 | · | · | · | |
| Cash / Share | $2.96 | $9.57 | $1.81 | $1.90 | $4.38 | $6.02 | |
| EPS (TTM) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -39.5% | -41.7% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | $6M | $0 | $0 | $0 | |
| Net Income TTM | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| Market Cap | $58M | $154M | $1.25B | $1.02B | $12.67B | $25.30B | |
| P/E | -3.8 | -1.9 | -0.5 | -10.6 | · | · | |
| P/S | 26.3 | 42.6 | 201.4 | · | · | · | |
| P/B | 1.1 | -5.3 | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Tangible Book | 1.1 | · | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Cash Flow | -0.7 | -1.9 | -15.8 | -12.9 | -109.5 | -340.7 | |
| P / FCF | · | -1.9 | -15.8 | -12.7 | -108.7 | -331.5 | |
| Earnings Yield | -26.3% | -52.6% | -206.0% | -9.4% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $3M | $169.0K | $741.0K | $965.0K | $311.0K | $606.0K | $1M | $1M | $694.0K | $672.0K | $1M | $4M | $140.0K | · | $0 | |
| R&D Expense | $24M | $23M | $17M | $24M | $14M | $15M | $16M | $17M | $21M | $16M | $22M | $16M | $17M | $18M | $19M | $18M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $5M | $5M | $5M | $6M | $7M | $6M | $6M | $9M | $9M | $7M | $5M | |
| Operating Expenses | $30M | $30M | $22M | $29M | $20M | $20M | $21M | $21M | $27M | $23M | $29M | $22M | $26M | $27M | $26M | $23M | |
| Operating Income | $-2M | $-27M | $-22M | $-28M | $-19M | $-19M | $-21M | $-20M | $-26M | $-22M | $-26M | $-19M | $-19M | $-24M | $-23M | $-19M | |
| Pretax Income | $1M | $-23M | $-20M | $-31M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-18M | $-23M | $-22M | $-19M | |
| Income Tax | $3M | $317.0K | $30.0K | $56.0K | $185.0K | $43.0K | $27.0K | $91.0K | $189.0K | $24.0K | $-30.0K | $29.0K | $757.0K | $39.0K | $49.0K | $-43.0K | |
| Net Income | $-2M | $-23M | $-20M | $-32M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-19M | $-23M | $-22M | $-19M | |
| EPS (Basic) | $-0.14 | $-2.21 | $-3.00 | $-3.04 | $-1.53 | $5.12 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| EPS (Diluted) | $-0.14 | $-2.21 | $4.23 | $-3.04 | $-1.53 | $-2.11 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| Shares (Basic) | 10,430,808 | 10,402,967 | · | 10,369,535 | 10,351,120 | 8,408,481 | · | 6,272,291 | 6,257,713 | 6,246,113 | · | 1,739,847 | 43,215,478 | 42,910,065 | · | 42,761,928 | |
| Shares (Diluted) | 10,430,808 | 10,402,967 | · | 10,369,535 | 10,351,120 | 8,709,693 | · | 6,272,291 | 6,265,853 | 6,246,113 | · | 1,739,847 | 43,215,478 | 42,910,065 | · | 42,761,928 | |
| EBITDA | · | $-27M | · | $-28M | $-19M | $-19M | · | $-20M | $-26M | $-22M | · | $-19M | $-19M | $-24M | · | $-19M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $18M | $42M | $19M | $74M | $37M | $35M | $45M | $24M | $136M | $70M | $91M | $79M | $81M | $86M | |
| Short-term Investments | $0 | $25M | $60M | $57M | $104M | $64M | $20M | $40M | $49M | $89M | · | · | $10.0K | $25M | $44M | $56M | |
| Receivables | $28M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $4M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $6M | $8M | $8M | |
| Current Assets | $62M | $60M | $83M | $103M | $128M | $143M | $62M | $80M | $100M | $118M | $141M | $75M | $94M | $109M | $134M | $150M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $15M | $15M | $15M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Accum. Depreciation | $13M | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | |
| Other Non-current Assets | $759.0K | $759.0K | $715.0K | $713.0K | $640.0K | $632.0K | $627.0K | $635.0K | $631.0K | $625.0K | $625.0K | $623.0K | $624.0K | $632.0K | $634.0K | $653.0K | |
| Total Assets | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Accounts Payable | $6M | $8M | $4M | $5M | $4M | $4M | $3M | $3M | $7M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | |
| Accrued Liabilities | $19M | $12M | $14M | $14M | $12M | $11M | $16M | $14M | $12M | $12M | $17M | $12M | $14M | $15M | $16M | $14M | |
| Current Liabilities | $28M | $23M | $21M | $22M | $20M | $19M | $22M | $21M | $24M | $19M | $24M | $22M | $27M | $28M | $33M | $31M | |
| Capital Leases | $288.0K | $659.0K | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $133.0K | |
| Total Liabilities | $34M | $33M | $35M | $38M | $33M | $34M | $99M | $38M | $42M | $68M | $59M | $31M | $36M | $37M | $43M | $42M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-667M | $-665M | $-642M | $-622M | $-591M | $-575M | $-618M | $-536M | $-517M | $-522M | $-487M | $-459M | $-441M | $-422M | $-399M | $-377M | |
| AOCI | $437.0K | $438.0K | $468.0K | $455.0K | $420.0K | $447.0K | $451.0K | $577.0K | $494.0K | $476.0K | $545.0K | $497.0K | $497.0K | $499.0K | $401.0K | $159.0K | |
| Stockholders' Equity | $32M | $32M | $54M | $72M | $102M | $116M | $-29M | $50M | $67M | $60M | $92M | $55M | $70M | $85M | $104M | $122M | |
| Liabilities + Equity | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Shares Outstanding | 6,236,828 | 6,188,186 | 6,178,230 | 6,153,507 | 6,151,274 | 6,114,801 | 3,864,436 | 3,324,780 | 79,785,898 | 75,668,521 | 3,003,855 | 43,502,582 | 43,502,582 | 42,940,089 | 42,922,980 | 42,815,593 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $959.0K | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Cash Flow | $-25M | $-23M | $-22M | $-24M | $-16M | $-21M | $-18M | $-20M | $-19M | $-23M | $-23M | $-20M | $-14M | $-22M | $-17M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $91.0K | $3.0K | |
| Investing Cash Flow | $25M | $35M | $-2M | $48M | $-39M | $-44M | $20M | $10M | $40M | $-89M | $-7.0K | $-9.0K | $25M | $20M | $12M | $32M | |
| Financing Cash Flow | $220.0K | $-62.0K | $123.0K | $-53.0K | $-177.0K | $102M | $97.0K | $-4.0K | $281.0K | $-19.0K | $88M | $-21.0K | $414.0K | $-1.0K | $121.0K | $-19.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-22M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| Net Margin | · | -814.1% | · | -4256.0% | -1643.8% | 13854.7% | · | -1540.7% | 477.0% | -5023.5% | · | -1662.8% | -437.6% | -16396.4% | · | · | |
| Pretax Margin | · | -802.9% | · | -4248.4% | -1624.7% | 13868.5% | · | -1533.4% | 494.8% | -5020.0% | · | -1660.1% | -420.0% | -16368.6% | · | · | |
| EBITDA Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| ROA | · | -21.4% | · | -31.8% | -13.0% | 30.9% | · | -22.1% | 4.7% | -27.9% | · | -14.4% | -13.0% | -13.8% | · | -8.7% | |
| ROE | · | -31.1% | · | -51.7% | -18.8% | 48.9% | · | -36.7% | 7.4% | -48.2% | · | -20.4% | -18.2% | -19.3% | · | -11.0% | |
| ROIC | · | -85.9% | · | -39.6% | -18.4% | -16.5% | · | -40.4% | -37.9% | -36.9% | · | -34.8% | -28.6% | -28.3% | · | -15.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | · | 4.7 | 6.3 | 7.6 | · | 3.8 | 4.2 | 6.3 | · | 3.3 | 3.5 | 3.9 | · | 4.9 | |
| Quick Ratio | · | 2.4 | · | 4.5 | 6.1 | 7.3 | · | 3.6 | 4.0 | 6.0 | · | 3.1 | 3.3 | 3.7 | · | 4.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $5.14 | · | $11.67 | $16.56 | $19.04 | · | $15.07 | $0.84 | $0.79 | · | $1.26 | $1.60 | $1.97 | · | $2.85 | |
| Revenue / Share | · | $0.27 | · | $0.07 | $0.09 | $0.04 | · | $0.20 | $0.01 | $0.00 | · | $0.02 | $0.10 | $0.00 | · | · | |
| Cash Flow / Share | · | $-2.22 | · | · | · | $-2.40 | · | · | · | $-0.15 | · | · | · | $-0.52 | · | · | |
| Cash / Share | · | $4.84 | · | $6.82 | $3.03 | $12.06 | · | $10.63 | $0.56 | $0.32 | · | $1.62 | $2.09 | $1.83 | · | $2.02 | |
| EPS (TTM) | $-1.16 | $-2.55 | · | $-19.78 | $-19.81 | $-17.47 | · | $-30.71 | $-38.01 | $-39.25 | · | $-11.83 | $-1.90 | $-1.94 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $5M | · | $3M | $3M | $3M | · | $4M | $4M | $7M | · | · | · | · | · | · | |
| Net Income TTM | $-76M | $-90M | · | $-86M | $-74M | $-53M | · | $-77M | $-76M | $-100M | · | $-82M | $-82M | $-83M | · | $-112M | |
| Market Cap | · | $46M | · | $60M | $44M | $50M | · | $29M | $698M | $1.85B | · | $812M | $1.06B | $938M | · | $1.18B | |
| P/E | -5.0 | -2.9 | · | -0.5 | -0.4 | -0.5 | · | -0.3 | -0.2 | -0.6 | · | -1.6 | -12.8 | -11.3 | · | · | |
| P/S | 9.6 | 9.8 | · | 23.0 | 14.2 | 15.6 | · | 7.8 | 198.8 | 274.9 | · | · | · | · | · | · | |
| P/B | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | -2.0 | · | · | · | -2.4 | · | · | · | -81.5 | · | · | · | -41.9 | · | · | |
| Earnings Yield | -20.1% | -34.3% | · | -201.8% | -274.8% | -211.8% | · | -354.6% | -434.4% | -160.2% | · | -63.3% | -7.8% | -8.9% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2M | $4M | $6M | $0 | $0 |
| Betriebsgewinnmarge % | -4024.9% | -2469.0% | -1423.5% | · | · |
| Nettoergebnis | $-24M | $-131M | $-88M | $-96M | $-128M |
| Verwässerte EPS | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 |
| Quick Ratio | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-81M | $-79M | $-80M | $-117M |
Institutionelle Eigentümer (13F) 34 Einreicher · $15.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
34
Gehaltener Wert
$15.3M
Neue Positionen
5
Geschlossene Positionen
9
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 5 (-2 vs. Vorquartal) | 9 (+2 vs. Vorquartal) | 7 (-1 vs. Vorquartal) | 7 (-2 vs. Vorquartal) | -483K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Deep Track Capital, LP | $2.562.515 | 444.110 | 16,70% | Aktien |
| Alyeska Investment Group, L.P. | $2.377.240 | 412.000 | 15,49% | Aktien |
| Sio Capital Management, LLC | $1.888.157 | 327.237 | 12,30% | Aktien |
| VANGUARD GROUP INC | $1.867.682 | 200.395 | 12,17% | Aktien |
| MARSHALL WACE, LLP | $1.422.761 | 246.579 | 9,27% | Aktien |
| Woodline Partners LP | $1.023.379 | 177.362 | 6,67% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.012.883 | 175.543 | 6,60% | Aktien |
| BAKER BROS. ADVISORS LP | $479.227 | 83.055 | 3,12% | Aktien |
| HHLR ADVISORS, LTD. | $439.945 | 76.247 | 2,87% | Aktien |
| D. E. Shaw & Co., Inc. | $383.491 | 66.463 | 2,50% | Aktien |
| UBS Group AG | $346.119 | 59.986 | 2,26% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $272.319 | 47.173 | 1,77% | Aktien |
| JANE STREET GROUP, LLC | $186.959 | 32.402 | 1,22% | Aktien |
| BlackRock, Inc. | $174.785 | 30.292 | 1,14% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $165.091 | 28.612 | 1,08% | Aktien |
| AlphaQuest LLC | $129.324 | 13.876 | 0,84% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $121.424 | 21.044 | 0,79% | Aktien |
| TWO SIGMA ADVISERS, LP | $121.160 | 13.000 | 0,79% | Aktien |
| Verition Fund Management LLC | $108.978 | 18.887 | 0,71% | Aktien |
| Trexquant Investment LP | $71.196 | 12.339 | 0,46% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $62.316 | 10.800 | 0,41% | Aktien |
| Rockefeller Capital Management L.P. | $57.700 | 10.000 | 0,38% | Aktien |
| Federation des caisses Desjardins du Quebec | $26.831 | 4.650 | 0,17% | Aktien |
| Golden State Wealth Management, LLC | $15.429 | 2.674 | 0,10% | Aktien |
| ROYAL BANK OF CANADA | $12.000 | 2.125 | 0,08% | Aktien |
| CITIGROUP INC | $10.432 | 1.808 | 0,07% | Aktien |
| Tower Research Capital LLC (TRC) | $2.071 | 359 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $1.868 | 344 | 0,01% | Aktien |
| MORGAN STANLEY | $1.177 | 204 | 0,01% | Aktien |
| SBI Securities Co., Ltd. | $727 | 126 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $577 | 100 | 0,00% | Aktien |
| FMR LLC | $58 | 10 | 0,00% | Aktien |
| ELEVATION WEALTH PARTNERS, LLC | $24 | 4 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $17 | 3 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Lawrence M. Blatt ×2 Einreichungen | 24. Juni 2026 | 5,60% | Erste Einreichung | Passive Anlage | SEC |
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×4 Einreichungen | 8. Februar 2024 | · | Erste Einreichung | · | SEC |
| Lawrence M. Blatt, Ph.D. | 6. November 2023 | · | Erste Einreichung | Passive Anlage | SEC |
| Novo Holdings A/S ×3 Einreichungen | 31. Januar 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 18 Insider · 8 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lawrence M. Blatt, Ph.D. | President and CEO | 9. März 2026 A | 1.847.575 | 0 | 0 | $0 |
| Lesley Ann Calhoun | Chief Operating Officer and Chief Financial Officer | 9. März 2026 A | · | 0 | 0 | $0 |
| Leonid Beigelman | President | 15. März 2023 A | 18.355 | 0 | 0 | $0 |
| Nikhil Aneja | Principal Accounting Officer | 9. März 2026 A | · | 0 | 0 | $0 |
| Julian A. Symons | Executive Vice President, Chief Scientific Officer | 9. März 2026 A | 394.064 | 0 | 0 | $0 |
| Hardean Achneck | Chief Medical Officer | 8. Oktober 2024 A | · | 0 | 0 | $0 |
| Matthew W. Mcclure | Chief Medical Officer | 1. März 2024 A | · | 0 | 0 | $0 |
| Lucinda Y. Quan | Executive Vice President, Chief Business Officer and General Counsel | 8. September 2023 A | 9.258 | 0 | 0 | $0 |
| Margarita Chavez | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Peter Hirth | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Carole Nuechterlein | Direktor | 25. Juni 2026 A | 11.025.941 | 0 | 0 | $0 |
| Bridget A Martell | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Heather Preston | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| James Paul Scopa | Direktor | 25. Juni 2026 A | 183.083 | 0 | 0 | $0 |
| Jack Nielsen | Direktor | 28. Februar 2024 A | · | 0 | 0 | $0 |
| Thomas Woiwode | Direktor | 23. Juni 2022 A | 4.452 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10%-Eigentümer | 20. Oktober 2020 C | 1.906.191 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 20. Oktober 2020 C | 2.614.563 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 6 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 16.320 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 1.149 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 2.810 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 46.773 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 128.770 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 1.855 NS | 31. Juli 2026 | N-PORT |
ALGS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$40.50
+631,0%
3 21,4%
Starker Kauf
10 71,4%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-02Mittelwert-Ziel $52.38 +845,4%
← Unter allen Zielen
Aktueller Preis $5.54
Tief$20.00
Mittelwert$52.38
Hoch$175.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026